行情

NBY

NBY

Novabay制药
AMEX
0.1105
-0.0098
-8.15%
盘后: 0.1130 +0.0025 +2.26% 19:53 09/29 EDT
开盘
0.1200
昨收
0.1203
最高
0.1201
最低
0.1080
成交量
121.42万
成交额
0
52周最高
0.6635
52周最低
0.1023
市值
591.32万
市盈率(TTM)
-0.9719
分时
5日
1月
3月
1年
5年
NovaBay Pharmaceuticals 预计将从私募、重新定价的认股权证中获得高达 530 万美元的收益
NovaBay Pharmaceuticals 预计将从私募、重新定价的认股权证中获得高达 530 万美元的收益
MT Newswires · 09/09 09:47
NBY 简况
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and sells consumer products for the eyecare and skincare markets. The Company's lead product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have antimicrobial properties as it removes foreign material, such as microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is formulated with its form of hypochlorous acid and is cleared by the United States Food and Drug Administration (FDA) for sale in the United States. Its other eyecare products offered under the Avenova eyecare brand include Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress and the i-Chek. Avenova Spray is available both over-the-counter and as a prescription. Avenova Spray is also available at optometrists and ophthalmologists offices; at national pharmacy chains across all over 50 states, and through its Partner Pharmacy Program.

微牛提供NovaBay Pharmaceuticals, Inc.(AMEX-NBY)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的NBY股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易NBY股票基本功能。